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Normal values of neutrophil-to-lymphocyte ratio, 
lymphocyte-to-monocyte ratio and platelet-to-lymphocyte 
ratio among Iranian population: Results of Tabari cohort 
 
Abstract 
Background: Neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR) and 
platelet-lymphocyte ratio (PLR) have a prognostic value in several types of diseases such 
as cancers and they vary in different races. So, we aimed to evaluate the normal range of 
these markers among healthy people to determine the normal value in Iranian population. 
Methods: In the present study, cross-sectional data of population-based cohort study 
named “Tabari cohort study” was utilized. In the first phase of Tabari cohort, 10255 
participants aged 35-70 years from urban and rural areas of Sari, Mazandaran, Iran entered 
into the study. The study included a questionnaire survey and blood collection. Blood 
samples were collected after 12 hours fasting from all participants during the study. 
Hematological indices were measured for all samples using Celltac Alpha MEK-6510 K 
(Tokyo, Japan). 
Results: After sample exclusion, 2212 healthy subjects of Tabari's normal cohort 
population were investigated. The mean age of the samples was 47.9±9.29 years. The 
mean of NLR, LMR, PLR were 1.70±0.70, 11.15±3.14 and 117.05±47.73, respectively. 
Conclusion: Our investigation provides preliminary reference values for NLR, LMR, and 
PMR among Iranian population that can be used for disease progress in various clinical 
procedures. 
Keywords: Normal values, Neutrophil-lymphocyte ratio, Lymphocyte-monocyte ratio, 
Platelet-lymphocyte ratio 
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Complete blood count (CBC) and differential leukocyte count called DIFF are the 
most common tests in clinical laboratories that can be measured by hematology auto-
analyzers, (automated hematology analyzer) cost-effectively, rapidly and accurately (1). 
Outcomes of these tests as hematology values have been widely used in the study of the 
individuals’ health status, and according to these values, various blood and non-blood 
disorders can be evaluated (2). Laboratory results have little clinical importance unless 
they are described by providing a comparison between health status and disease. 
Therefore, the reference values are important in this regard, which provides the results of a 
seemingly healthy population. In addition, given that the values obtained in healthy 
subjects and patients can have significant overlaps, they should not be considered as an 
absolute indicator of health (3). Hematologic values are influenced by factors such as age, 
sex, race, nutrition, environment, above mean sea level, time and measurement methods.  
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Therefore, when these are different in various 
populations, this diversity can lead to differences in 
reference values (2, 4). Since studies showed that alteration 
in the amount of peripheral blood cell can demonstrate the 
body inflammatory response, several investigations have 
indicated that blood-based indicators such as neutrophil to-
lymphocyte ratio (NLR), lymphocyte to monocyte ratio 
(LMR) and platelet to lymphocyte ratio (PLR) can play a 
role as a potential prognostic indicator for various types of 
cancers (5-7). 
Furthermore, in detail, NLR is known as an inflammatory 
marker as well as a significant prognostic factor for disorders 
such as cardiovascular diseases (8), different types of 
malignancies (9-12) and inflammatory bowel disease (IBD) 
(13). It is remarkable that inflammation as a biological 
response of the body against adverse stimuli plays a 
significant role in the development of cancer (14, 15). 
Systematic inflammation may have an effect on tumor 
microenvironment to the progression of the malignancy, 
which indicates a poor prognosis (16). 
Moreover, previous studies showed that both LMR and 
PLR could play the same role as NLR in disorders such as 
gastric cancer (12) and urothelial carcinoma (17) 
respectively. Besides, several systematic review and meta-
analyses have carried out to prove the prognostic effect of 
these indicators in solid tumors (18), breast neoplasm (19), 
stomach cancer (20), colorectal cancer (21), pulmonary 
cancer (22), etc. 
In addition, although numerous studies have evaluated 
the impact of these indicators, normal values differ between 
them and it shows a considerable difference throughout the 
world among various ethnicities (23, 24). When these 
markers can be measured through a CBC test, which is a 
simple and cost-effective way, we can use these indicators in 
clinical process easily to detect a disorder or health follow-
up in both the patients and the healthy population. Also, 
accordingly these indexes can be used as a prognostic factor, 
we need to know its normal values in each population to 
determine the cutoff points to use and compare them as 
normal values in later studies.  
Hence, as far as we know, there is no investigation 
regarding the normal range of NLR, LMR and PLR in 
Iranian population, we aimed to study the normal range of 
these markers and their relationships with demographic 
factors among healthy population contributing Tabari cohort 
in Iran. 
Methods 
Population and study design: In the present study, we 
utilized cross-sectional data of population based cohort study 
named “Tabari cohort study”. In phase I of Tabari cohort, we 
registered 10255 participants aged between 35-70 from 
urban and rural areas of Sari city, Mazandaran, Iran (7012 
urban and 3243 rural residents). It is worth mentioning that 
Tabari cohort is part of a nationwide cohort called 
“Prospective Epidemiological Research Studies in IRAN 
(PERSIAN) cohort” (25, 26). The study included a questionnaire 
survey and blood collection. Exclusion criteria of this study 
were as follows: participants with body mass index (BMI) 
less than 18 and greater than 30, individuals with at least one 
of the disorders including diabetes, hypertension, ischemic 
heart disease, stroke, myocardial infarction, renal failure, 
fatty liver, hepatitis B and C, asthma, thyroid disorders, 
kidney stone, gallstone, epilepsy, depression and other 
mental disorder, lupus erythematosus, multiple sclerosis 
(MS), any types of cancer and current smokers.  
Body mass index: BMI was measured by trained persons 
based on standardized methodology. Weight was measured 
using a calibrated balance scale of SECA 755 (SECA, 
Hamburg, Germany). To measure height, we used SECA 
226 (SECA, Hamburg, Germany). 
Blood collection: During the study, blood samples were 
collected after 12 hours fasting from all participants. 
Hematological indices were measured for all samples using 
Celltac Alpha MEK-6510 K (Tokyo, Japan). Lymphocyte, 
monocyte, neutrophil and platelet were reported as 
percentage and NLR, LMR and PLR were calculated. 
Statistical Analysis: All statistical analyses were performed 
using Statistical Package for the Social Sciences (SPSS) 
software Version 24. Parameters such as percentage, mean 
and standard deviation (M±SD), median, range, minimum 
and maximum were used for data analysis. We used 
independent t-test and analysis of variance (ANOVA) to 
compare hematological indices and sex as well as residency 
and age groups, respectively. 
 
 
Results 
In this study, 2212 subjects of Tabari's normal cohort 
population were investigated. The mean, standard deviation, 
median, minimum and maximum range of the samples’ age 
were 47.9, 9.29, 45, 35 and 70 years old, respectively. The 
subjects comprised 1120 (50.6%) females and the majority 
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of the subjects were urban population (67%). The mean, 
standard deviation, average, and, minimum and maximum 
BMI of the subjects were 25.5, 2.77, 25.86, 18.07 and 29.99, 
respectively. The mean neutrophil-to-lymphocyte ratio in the 
whole population was 1.70±0.70 (Range: 8.38, Min: 0.23, 
Max: 8.61), mean lymphocyte-to-monocyte ratio was 
11.15±3.14 (Range:23.21, Min:3.46, Max:26.67), and mean 
platelet-to-lymphocyte ratio was 117.05±47.73 
(Range:93.60, Min:19.11, Max:1598.77).  
The mean lymphocyte-to-monocyte ratio was 
significantly higher in females than males (11.60±3.29 vs. 
10.69±2.91; P<0.001), and it was higher in the urban 
population than the rural (11.38±3.24 vs. 10.68±2.88; 
P<0.001).  In addition, the highest lymphocyte-to-monocyte 
ratio was observed in the age group under 40 years old (table 
1). According to the results of Tukey's test, the differences 
observed in the mean lymphocyte-to-monocyte ratio among 
all age groups (except the age group of 40-49 years and 50-
59 years) were statistically significant.  
The mean platelet-to-lymphocyte ratio was significantly 
higher in females than males (110.84±56.53 V.S 
123.12±36.21; P<0.001). There was no significant difference 
between mean platelet-to-lymphocyte ratios among various 
age groups and rural or urban populations (table 2). Also, the 
mean neutrophil-to-lymphocyte ratio was not significantly 
different in terms of sex, age group, and residence (Table 3). 
 
Table 1. The mean lymphocyte-monocyte ratio according to sex, age and area residence. 
Variables n Mean±SD 95% CI mean Min Max P-value 
Sex 
Male 1092 10.69±2.91 10.52-10.86 3.46 26.50 
<0.001 
Female 1120 11.60±3.29 11.41-11.79 4.12 26.67 
Age group 
<40 642 11.73±3.54 11.45-12.00 5.95 26.67 
<0.001 
40-49 747 11.14±2.91 10.94-11.35 4.35 23.12 
50-59 543 10.91±3.11 10.65-11.18 3.46 26.50 
>=60 280 10.29±2.52 9.99-10.59 3.98 19.55 
Residence 
Urban 1482 11.38±3.24 11.22-11.55 3.46 26.67 
<0.001 
Rural 730 10.68±2.88 10.47-10.89 3.98 26.50 
 
Table 2. The mean platelet-lymphocyte ratio according to sex, age and area residence. 
Variables n Mean±SD 95% CI mean Min Max P-value 
Sex 
Male 1092 110.84±56.53 107.48-114.19 19.11 1598.77 
<0.001 
Female 1120 123.12±36.21 120.99-125.24 33.21 322.59 
Age group 
<40 642 114.71±35.89 111.92-117.49 41.71 322.58 
0.358 
40-49 747 117.23±35.46 114.68-119.78 19.11 332.13 
50-59 543 117.76±71.62 111.72-123.80 40.99 1598.77 
>=60 280 120.59±41.71 115.69-125.50 33.21 398.66 
Residence 
Urban 1482 115.90±51.89 113.26-118.55 40.99 1598.77 
0.106 
Rural 730 119.39±37.82 116.64-122.14 19.11 336.52 
 
Table 3. The mean neutrophil-lymphocyte ratio according to sex, age and area residence. 
Variables n Mean±SD 95% CI mean Min Max P-value 
Sex 
Male 1092 1.69±0.69 1.65-1.73 0.43 8.61 
0.574 
Female 1120 1.71±0.71 1.67-1.75 0.23 7.63 
Age group 
<40 642 1.72±0.75 1.66-1.78 0.43 7.63 
0.162 
40-49 747 1.73±0.73 1.68-1.79 0.51 8.61 
50-59 543 1.65±0.62 1.60-1.71 0.23 4.74 
>=60 280 1.67±0.66 1.59-1.75 0.55 4.27 
Residence 
Urban 1482 1.69±0.67 1.66-1.73 0.54 8.61 
0.584 
Rural 730 1.71±0.76 1.66-1.77 0.23 7.63 
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The highest mean lymphocyte-to-monocyte ratio was 
observed in male subjects in age group less than 40 years, 
and the highest platelet-to-lymphocyte ratio and neutrophil-
to-lymphocyte ratio were observed in the 60-year-old age 
group and higher (Table 4).  
According to the results of Tukey's test, a significant 
difference was observed in the mean neutrophil-to-
lymphocyte ratio in males in the age group of less than 40 
and 50-59 (P=0.009), and, the age group of less than 40 with 
the 60-year-old age group and higher (P=0.026). The mean 
platelet-to-lymphocyte ratio in males showed a significant 
difference under the 40-year-old age group and 50-59 years 
old (P=0.022).  
In addition, table 4 shows that the highest lymphocyte-to-
monocyte ratio, neutrophil-to-lymphocyte ratio, and platelet-
to-lymphocyte ratio were observed in females under 40 years 
old. According to the results of Tukey's test, in females, a 
significant difference was observed in neutrophil-to-
lymphocyte ratio in under 40-year-old age group and 50-59 
years old (P<0.001), under 40-year-old age group and 60 
years old (P=0.001), 40-49-year-old age group and 50-59 
years old (P<0.001) and 40-49-year-old age group with 60 
years old and higher (P=0.007).  
A significant difference was observed in the mean 
lymphocyte-to-monocyte ratio under the 40-year-old age 
group and 40-49 years old (P=0.004), 50-59 years old 
(P<0.001), 60 years old and higher (P<0.001) and between 
the 60-year-old age group and higher with 40-49 years old 
group (P=0.023). Additionally, a significant difference was 
observed in the mean platelet-to-lymphocyte ratio under the 
40-year-old age group and 50-59-year-old group (P=0.002), 
and 50-59-year-old age group (P=0.003). 
 
Table 4. The mean lymphocyte-monocyte ratio, platelet-lymphocyte ratio and neutrophil-lymphocyte ratio by sex and age group 
Variables 
Male Female 
<40 40-49 50-59 >=60 
P-
value 
<40 40-49 50-59 >=60 
P-
value 
LMR 10.88±3.03 10.75±2.79 10.75±3.09 10.17±2.55 0.079 12.27±3.73 11.49±2.97 11.16±3.14 10.49±2.48 <0.001 
PLR 101.51±28.12 108.69±32.95 116.47±88.64 118.07±43.45 0.004 123.06±37.77 124.64±35.94 119.70±32.32 124.50±38.72 0.425 
NLR 1.57±0.65 1.69±0.78 1.75±0.61 1.76±0.64 0.007 1.81±0.79 1.77±0.68 1.50±0.61 1.53±0.65 <0.001 
 
Discussion 
Our investigation shows the first report of a cut-off 
values for NLR, LMR, and PLR in more than 2000 subjects 
among the Iranian population. There are few researches, 
which reported the normal values for these indicators. As far 
as we know, our study is the first study that made this 
comparison between these indicators by age, sex and 
residence among the healthy subjects of the Iranian 
population. In the present study, the mean NLR was 
1.70±0.70 and it was not significantly different in terms of 
sex (P=0.574), age group (P=0.162), and place of residence 
(P=0.584). A few studies reported the NLR in healthy 
population. Azab et al.’s study in 2014, reported the mean 
NLR among 9427 samples in the “U.S. National Health and 
Nutrition Examination Survey”, in this study,  the mean 
NLR was 2.15 (23) that was higher than our study, but in 
Forget et al’s study in 2017, the mean NLR was  1.65 (28), 
while in Lee et al.’s study, it was 1.65 (28) and in Kweon et 
al. study, was 1.53 (29), which were lower than our study. In 
our study, there were no significant NLR differences for sex 
(P=0.574), which were consistent with the results of Azab et  
 
 
al.’s (23) Kweon et al.’s and (29) Lee et al.’s (28) studies. In 
contrast to the present study, in Azab et al.’s (23) and  
Kweon et al.’s (29) studies, the relationship between NLR 
and age was reversed. In comparison to other studies, we 
found that the NLR of an Iranian population was more than 
the NLR of some other races. Besides, age distribution 
within the study populations may be one other possible 
causing this difference. 
The mean LMR was 11.15±3.14 which was significantly 
higher in females (P<0.001), urban population (P<0.001) and  
age group under 40 years (P<0.001) compared to males, 
rural population and other age groups. The LMR among 
healthy population has been examined only in one study. 
This ratio in Lee et al. study was 5.31. In females, the LMR 
was more than in males (28) and in comparison with the 
present study, the LMR of an Iranian population was higher 
than the Korean population. These differences could be due 
to differences in the sampling approach except race and age 
distribution differences. The mean PLR was 117.05±47.73, 
which was significantly higher in females than males 
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(P<0.001), but there was no significant difference between 
mean PLR among various age groups (P=0.358) and rural or 
urban population (P=0.106). The PLR among healthy 
population has been examined only in a few investigations. 
A study performed by Lee et al. (28) in 2018 reported the 
mean 132.4 for PLR, which was higher than our study. In 
Kweon et al.’s study (29), PLR was 121.07 which was lower 
than our study. It is remarkable that different types of 
secreted substances of platelets play mediatory role in 
coagulation, thrombosis, and inflammation process. For 
example, inflammatory states such as cancer effects on count 
and volume of platelet (28).  
In limitation, the calculation in the present study was 
included with single measures and variations could not be 
determined with time, but as a strength, the study was based 
on cohort study’s data and the selection of a normal 
population among this population, because the subjects with 
history of disease and main risk factor were excluded. 
In conclusion, the present study provides preliminary 
reference value for NLR, LMR, and PMR among the Iranian 
population. The data indicate that various cutoff scores 
should be considered according to sex, age and residence, 
especially for LMR. These reference values can be used for 
disease progress in various clinical procedures. 
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